TY - JOUR
T1 - Neuronal DAMPs exacerbate neurodegeneration via astrocytic RIPK3 signaling
AU - Chang, Nydia P.
AU - DaPrano, Evan M.
AU - Lindman, Marissa
AU - Estevez, Irving
AU - Chou, Tsui Wen
AU - Evans, Wesley R.
AU - Nissenbaum, Marialaina
AU - McCourt, Micheal
AU - Alzate, Diego
AU - Atkins, Colm
AU - Kusnecov, Alexander W.
AU - Huda, Rafiq
AU - Daniels, Brian P.
N1 - Publisher Copyright: © 2024, Chang et al.
PY - 2024/6/10
Y1 - 2024/6/10
N2 - Astrocyte activation is a common feature of neurodegenerative diseases. However, the ways in which dying neurons influence the activity of astrocytes is poorly understood. Receptor interacting protein kinase-3 (RIPK3) signaling has recently been described as a key regulator of neuroinflammation, but whether this kinase mediates astrocytic responsiveness to neuronal death has not yet been studied. Here, we used the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson’s disease to show that activation of astrocytic RIPK3 drives dopaminergic cell death and axon damage. Transcriptomic profiling revealed that astrocytic RIPK3 promoted gene expression associated with neuroinflammation and movement disorders, and this coincided with significant engagement of damage-associated molecular pattern signaling. In mechanistic experiments, we showed that factors released from dying neurons signaled through receptor for advanced glycation endproducts to induce astrocytic RIPK3 signaling, which conferred inflammatory and neurotoxic functional activity. These findings highlight a mechanism of neuron-glia crosstalk in which neuronal death perpetuates further neurodegeneration by engaging inflammatory astrocyte activation via RIPK3.
AB - Astrocyte activation is a common feature of neurodegenerative diseases. However, the ways in which dying neurons influence the activity of astrocytes is poorly understood. Receptor interacting protein kinase-3 (RIPK3) signaling has recently been described as a key regulator of neuroinflammation, but whether this kinase mediates astrocytic responsiveness to neuronal death has not yet been studied. Here, we used the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson’s disease to show that activation of astrocytic RIPK3 drives dopaminergic cell death and axon damage. Transcriptomic profiling revealed that astrocytic RIPK3 promoted gene expression associated with neuroinflammation and movement disorders, and this coincided with significant engagement of damage-associated molecular pattern signaling. In mechanistic experiments, we showed that factors released from dying neurons signaled through receptor for advanced glycation endproducts to induce astrocytic RIPK3 signaling, which conferred inflammatory and neurotoxic functional activity. These findings highlight a mechanism of neuron-glia crosstalk in which neuronal death perpetuates further neurodegeneration by engaging inflammatory astrocyte activation via RIPK3.
UR - http://www.scopus.com/inward/record.url?scp=85195668526&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85195668526&partnerID=8YFLogxK
U2 - 10.1172/jci.insight.177002
DO - 10.1172/jci.insight.177002
M3 - Article
C2 - 38713518
SN - 2379-3708
VL - 9
JO - JCI Insight
JF - JCI Insight
IS - 11
M1 - e177002
ER -